Search
for
Sort by
Research 61–90 of 1000+
- Actualités réglementaires relatives aux produits cosmétiques
- The Case Files
- Classified Advertising
- Protein Kinase C Epsilon Signals Ultraviolet Light-induced Cutaneous Damage and Development of Squamous Cell Carcinoma Possibly Through Induction of Specific Cytokines in a Paracrine Mechanism¶
- Heat shock protein 25 plays multiple roles during mouse skin development
- Micronutrient deficiency in menstrual dysfunction among women of reproductive age
- Synaptic processes and immune-related pathways implicated in Tourette syndrome
- Synaptic processes and immune-related pathways implicated in Tourette Syndrome
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Finasteride 5 mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal women
- Drug-induced hair colour changes
- Dermoscopy of scalp tumours: a multi‐centre study conducted by the international dermoscopy society
- Pilotropic Mycosis fungoides
- Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- An Interesting Case of Hepatic Adrenocortical Carcinoma.
- Advanced Breast Cancer in Young Women
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- A comment on psychological distress and women’s hair loss related to the COVID-19 pandemic
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Stigmatizing attitudes towards facial psoriasis, atopic dermatitis, vitiligo and alopecia areata
- An Early Hair Loss Detection and Prediction Method Based on Machine Learning
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Effectiveness of Baricitinib in Alopecia Areata Patients With a Current Episode Lasting Longer Than 8 Years: An Italian Multicenter Real‐Life Experience in the Lazio Region
- Afectación pulmonar en pacientes con neumonia por COVID-19
- Line‐field confocal optical coherence tomography in alopecia areata and histopathological correlation